| IDH purchases additional 49% stake in Biolab KSA |
9 Dec 2024 |
| EGX Delisting – timeline under EGX's special operations market (OPR) |
13 Aug 2024 |
| IDH - LSE - Revised Buyback Price Announcement |
27 Jun 2024 |
| IDH reports 1Q2024 results |
30 May 2024 |
| Extraordinary General Meeting 2024 Announcement |
26 May 2024 |
| Proposed Delisting from EGX - Chairman's Letter and Notice of Extraordinary General Meeting |
26 May 2024 |
| Disclosure report in relation to the procedures of the voluntary delisting of the shares of IDH from the Egyptian Exchange |
19 May 2024 |
| Minutes of the Board of Directors Meeting held on 15 May 2024 |
19 May 2024 |
| IDH proposing to delist its shares from the Egyptian Exchange |
16 May 2024 |
| IDH reports FY2023 results |
28 Mar 2024 |
| IDH appoints Sherif El Zeiny as Board Member, Vice President and Group Chief Financial Officer |
18 Jan 2024 |
| IDH reports 9M2023 results |
16 Nov 2023 |
| IDH CEO increases stake in the Company |
25 Oct 2023 |
| IDH reports 1H2023 results |
31 Aug 2023 |
| IDH appoints new Chief Financial Officer and Strategic Investment Officer |
21 Jun 2023 |
| IDH reports 1Q2023 results |
1 Jun 2023 |
| IDH reports FY2022 results |
6 Apr 2023 |
| IDH to no longer pursue acquisition of IDC stake |
31 Jan 2023 |
| IDH reports 9M2022 results |
17 Nov 2022 |
| IDH to Launch Greenfield Diagnostic Venture in Saudi Arabia |
31 Oct 2022 |
| IDH launches sixth Al-Borg Scan Branch in Cairo’s Maadi Neighbourhood |
5 Oct 2022 |
| Al-Borg Scan’s Nuclear Medicine and Ultrasound Units Earn Prestigious ACR Accreditation |
5 Oct 2022 |
| IDH reports 1H2022 results |
12 Sep 2022 |
| SPA for IDH's acquisition of a stake in IDC expires; negotiations to continue |
6 Sep 2022 |
| IDH CEO ups stake in the Company |
16 Aug 2022 |
| Statement regarding final dividend declared on 7 June 2022 |
27 Jul 2022 |
| IDH reports 1Q2022 results |
8 Jun 2022 |
| IDH reports FY2021 results |
21 Apr 2022 |
| IFC and IFC MENA Fund acquire 5% stake in IDH |
31 Mar 2022 |
| IDH launches fifth Al-Borg Scan branch in West Cairo’s Capital Business Park |
29 Mar 2022 |
| IDH Welcomes Visit from Siemens Healthineers |
27 Mar 2022 |
| IDH announces the appointment of Ms Yvonne Stillhart as a Non-Executive Director of the Company |
1 Mar 2022 |
| Pakistan's Ambassador to Egypt visits IDH headquarters to explore relationships between IDH and Pakistani companies |
23 Jan 2022 |
| IDH to acquire Evercare Group’s 50% stake in Islamabad Diagnostic Centre (IDC) |
20 Dec 2021 |
| IDH reports 9M2021 results |
16 Nov 2021 |
| IDH launches third Al-Borg Scan branch in East Cairo’s centrally-located Heliopolis neighbourhood |
4 Oct 2021 |
| IDH reports 1H2021 results |
2 Sep 2021 |
| Biolab selected as preferred bidder to operate testing stations in Amman’s Queen Alia International Airport |
18 Aug 2021 |
| IDH reports 1Q2021 results |
2 Jun 2021 |
| IDH partners with IFC on USD 45M debt financing |
25 May 2021 |
| IDH’s dual-listed ordinary shares begin trading today on the Egyptian Exchange, complementary to their trading on the LSE |
20 May 2021 |
| IDH reports FY20 results |
18 May 2021 |
| IDH receives approval from the Egyptian Exchange for the dual listing of its ordinary shares |
5 May 2021 |
| IDH receives FRA registration approval as a preliminary step for its dual listing and trading on the Egyptian Exchange |
22 Mar 2021 |
| CEO Dr. Hend El Sherbini — cover story in Forbes Middle East (20 mb pdf download) |
13 Apr 2020 |
| Covid-19 protocols statement |
24 Mar 2020 |
